Glen C. Post, Ph.D.
Affiliations: | 2006 | University of Colorado, Boulder, Boulder, CO, United States |
Area:
Organic Chemistry, Pharmaceutical ChemistryGoogle:
"Glen Post"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Tad Harbison Koch | grad student | 2006 | CU Boulder | |
| (Design, synthesis, and biological evaluation of anthracycline-formaldehyde conjugates.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Koch TH, Barthel BL, Kalet BT, et al. (2008) Anthracycline-formaldehyde conjugates and their targeted prodrugs. Topics in Current Chemistry. 283: 141-70 |
| Spencer DM, Bilardi RA, Koch TH, et al. (2008) DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair. Mutation Research. 638: 110-21 |
| Burkhart DJ, Barthel BL, Post GC, et al. (2006) Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases. Journal of Medicinal Chemistry. 49: 7002-12 |
| Post GC, Barthel BL, Burkhart DJ, et al. (2005) Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA. Journal of Medicinal Chemistry. 48: 7648-57 |
| Burkhart DJ, Kalet BT, Coleman MP, et al. (2004) Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin. Molecular Cancer Therapeutics. 3: 1593-604 |
| Cogan P, Fowler C, Post G, et al. (2004) Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate Letters in Drug Design & Discovery. 1: 247-255 |
| Kato S, Post GC, Bierbaum VM, et al. (2002) Chemical ionization mass spectrometric determination of acrolein in human breast cancer cells. Analytical Biochemistry. 305: 251-9 |